Logo image of CTOR

CITIUS ONCOLOGY INC (CTOR) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:CTOR - US17331Y1091 - Common Stock

1.08 USD
+0.08 (+8%)
Last: 1/2/2026, 4:36:33 PM
1.06 USD
-0.02 (-1.85%)
After Hours: 1/2/2026, 4:36:33 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
CTOR revenue by date.CTOR revenue by date.
N/AN/AN/A
90.40%
EBITDA
YoY % growth
CTOR ebitda by date.CTOR ebitda by date.
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CTOR ebit by date.CTOR ebit by date.
-4.857M-12.121M
-149.58%
-20.573M
-69.73%
N/A
-18.27%
N/A
170.70%
N/A
260.29%
Operating Margin
CTOR operating margin by date.CTOR operating margin by date.
N/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CTOR eps by date.CTOR eps by date.
N/AN/AN/A-0.34N/A
115.00%
N/A
960.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.06
168.00%
0.01
109.27%
0.07
189.25%
-0.09
-53.00%
0.12
100.00%
0.13
1,200.00%
0.14
100.00%
0.14
255.56%
Revenue
Q2Q % growth
4.46M12.744M19.116M20.072M24.417M
447.47%
25.479M
99.93%
27.601M
44.39%
28.663M
42.80%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-3.26M
49.02%
2.217M
129.67%
6.384M
229.10%
6.863M
233.39%
11.571M
454.95%
12.074M
444.61%
13.08M
104.89%
13.583M
97.92%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2025
Q2Q % growth
-0.06 -0.120.0650.98%
Q3 2025
Q2Q % growth
-0.08 -0.150.0747.71%
Q2 2025
Q2Q % growth
-0.11 -0.09-0.02-19.83%
Q1 2025
Q2Q % growth
-0.09 -0.06-0.03-47.06%
CTOR Yearly EPS VS EstimatesCTOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.2 -0.2 0.4 -0.4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
5.851M-5.851M-100.00%
CTOR Yearly Revenue VS EstimatesCTOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
RevenueN/A N/A N/A N/A